{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T12:11:17Z","timestamp":1648642277425},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T00:00:00Z","timestamp":1348617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00292-012-1662-0","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T20:58:01Z","timestamp":1348606681000},"page":"253-257","source":"Crossref","is-referenced-by-count":3,"title":["Update zum Barrett-\u00d6sophagus und Barrett-Karzinom"],"prefix":"10.1007","volume":"33","author":[{"given":"M.","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"La\u00dfmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,26]]},"reference":[{"key":"1662_CR1","first-page":"18","volume":"140","author":"American","year":"2011","unstructured":"American Gastroenterological Association, Spechler SJ, Sharma P et al (2011) American Gastroenterological Association medical position statement on the management of Barrett\u2019s esophagus. Gastroenterology 140:18\u201352","journal-title":"Gastroenterology"},{"key":"1662_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrgastro.2010.78","volume":"7","author":"Badreddine","year":"2010","unstructured":"Badreddine RJ, Wang KK (2010) Barrett esophagus: an update. Nat Rev Gastroenterol Hepatol 7:369\u2013378","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1662_CR3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687\u2013697","journal-title":"Lancet"},{"key":"1662_CR4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.humpath.2011.04.018","volume":"43","author":"Brankley","year":"2012","unstructured":"Brankley SM, Fritcher EGB, Smyrk TC et al (2012) Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett\u2019s esophagus with high-grade dysplasia or adenocarcinoma. Hum Pathol 43:172\u2013179","journal-title":"Hum Pathol"},{"key":"1662_CR5","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.athoracsur.2011.06.091","volume":"92","author":"Bollschweiler","year":"2011","unstructured":"Bollschweiler E, H\u00f6lscher AH, Metzger R et al (2011) Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer. Ann Thorac Surg 92:2020\u20132027","journal-title":"Ann Thorac Surg"},{"key":"1662_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2005-857870","volume":"43","author":"Koop","year":"2005","unstructured":"Koop H, Schepp W, M\u00fcller-Lissner S et al (2005) Consensus conference of the DGVS on gastroesophageal reflux. Gastroenterology 43:163\u2013164","journal-title":"Gastroenterology"},{"key":"1662_CR7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/00365520701879831","volume":"43","author":"Gatenby","year":"2008","unstructured":"Gatenby PAC, Ramus JR, Caygill CPJ et al (2008) Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus. Scand J Gastroenterol 43:524\u2013530","journal-title":"Scand J Gastroenterol"},{"key":"1662_CR8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/PAS.0b013e31819f57e9","volume":"33","author":"Hahn","year":"2009","unstructured":"Hahn HP, Blount PL, Ayub K et al (2009) Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol 33:1006\u20131015","journal-title":"Am J Surg Pathol"},{"key":"1662_CR9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM et al (2011) Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med 365:1375\u20131383","journal-title":"N Engl J Med"},{"key":"1662_CR10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/00365520701420735","volume":"42","author":"Kelty","year":"2007","unstructured":"Kelty CJ, Gough MD, Van Wyk Q et al (2007) Barrett\u2019s oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 42:1271\u20131274","journal-title":"Scand J Gastroenterol"},{"key":"1662_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1749-6632.2011.06055.x","volume":"1232","author":"Komanduri","year":"2011","unstructured":"Komanduri S, Deprez PH, Atasoy A et al (2011) Barrett\u2019s esophagus: treatments of adenocarcinomas I. Ann N Y Acad Sci 1232:248\u2013264","journal-title":"Ann N Y Acad Sci"},{"key":"1662_CR12","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1158\/1078-0432.CCR-06-0189","volume":"12","author":"Kwak","year":"2006","unstructured":"Kwak EL, Jankowski J, Thayer SP et al (2006) Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res 12:4283\u20134287","journal-title":"Clin Cancer Res"},{"key":"1662_CR13","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-05-0042","volume":"11","author":"Langer","year":"2005","unstructured":"Langer R, Specht K, Becker K et al (2005) Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res 11:7462\u20137469","journal-title":"Clin Cancer Res"},{"key":"1662_CR14","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1200\/JCO.2011.35.4928","volume":"29","author":"Lennerz","year":"2011","unstructured":"Lennerz JK, Kwak EL, Ackerman A et al (2011) MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol 29:4803\u20134810","journal-title":"J Clin Oncol"},{"key":"1662_CR15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ajg.2009.85","volume":"104","author":"Liu","year":"2009","unstructured":"Liu W, Hahn H, Odze RD, Goyal RK (2009) Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 104:816\u2013824","journal-title":"Am J Gastroenterol"},{"key":"1662_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2559.2010.03643.x","volume":"57","author":"Marx","year":"2012","unstructured":"Marx AH, Zielinski M, Kowitz CM et al (2012) Homogeneous EGFR amplification defines a subset of aggressive Barrett\u2019s adenocarcinomas with poor prognosis. Histopathology 57:418\u2013426","journal-title":"Histopathology"},{"key":"1662_CR17","first-page":"4819","volume":"9","author":"Miller","year":"2003","unstructured":"Miller CT, Moy JR, Lin L et al (2003) Gene amplification in esophageal adenocarcinomas and Barrett\u2019s with high-grade dysplasia. Clin Cancer Res 9):4819\u20134825","journal-title":"Clin Cancer Res"},{"key":"1662_CR18","unstructured":"Paterson AL, O\u2019Donovan M, Provenzano E et al (2012) Characterisation of the timing and prevalence of receptor tyrosine kinase expression changes in esophageal carcinogenesis. J Pathol. DOI 10.1002\/path.4044 [Epub ahead of print]"},{"key":"1662_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1442-2050.2007.00630.x","volume":"20","author":"P\u00fchringer-Oppermann","year":"2007","unstructured":"P\u00fchringer-Oppermann FA, Stein HJ, Sarbia M (2007) Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett\u2019s) adenocarcinomas. Dis Esophagus 20:9\u201311","journal-title":"Dis Esophagus"},{"key":"1662_CR20","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/1078-0432.CCR-07-0465","volume":"13","author":"Rauser","year":"2007","unstructured":"Rauser S, Weis R, Braselmann H et al (2007) Significance of HER2 low-level copy gain in Barrett\u2019s cancer: implications for fluorescence in situ hybridization testing in tissues. Clin Cancer Res 13:5115\u20135123","journal-title":"Clin Cancer Res"},{"key":"1662_CR21","first-page":"1065","volume":"30","author":"Schauer","year":"2010","unstructured":"Schauer M, Knoefel WT (2010) Neoadjuvant chemotherapy in Barrett\u2019s carcinoma\u2014prognosis and response prediction. Anticancer Res 30:1065\u20131070","journal-title":"Anticancer Res"},{"key":"1662_CR22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000658-200012000-00002","volume":"232","author":"Stein","year":"2000","unstructured":"Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett\u2019s esophagus. Ann Surg 232:733\u2013742","journal-title":"Ann Surg"},{"key":"1662_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2008.06.008","volume":"40","author":"Takubo","year":"2009","unstructured":"Takubo K, Aida J, Naomoto Y et al (2009) Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 40:65\u201374","journal-title":"Hum Pathol"},{"key":"1662_CR24","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"Van","year":"2012","unstructured":"Van Hagen P, Hulshof MC, Lanschot JJ van et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. CROSS Group. N Engl J Med 366:2074\u20132084","journal-title":"N Engl J Med"},{"key":"1662_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1155\/2000\/947249","volume":"20","author":"Walch","year":"2000","unstructured":"Walch A, Bink K, Gais P et al (2000) Evaluation of c-erbB-2 overexpression and Her-2\/neu gene copy number heterogeneity in Barrett\u2019s adenocarcinoma. Anal Cell Pathol 20:25\u201332","journal-title":"Anal Cell Pathol"},{"key":"1662_CR26","first-page":"1","volume":"Gastroenterol","author":"Watson","year":"2005","unstructured":"Watson A, Heading RC, Shepherd NA (2005) Guidelines for the diagnosis and management of Barrett\u2019s columnar-lined oesophagus: a report of the working party of the British society of gastroenterology. BSG Guidelines Gastroenterol:1\u201342","journal-title":"BSG Guidelines"},{"key":"1662_CR27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/1078-0432.CCR-11-2272","volume":"18","author":"Yoon","year":"2012","unstructured":"Yoon HH, Shi Q, Sukov WR et al (2012) Association of HER2\/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. Clin Cancer Res 18:546\u2013554","journal-title":"Clin Cancer Res"},{"key":"1662_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/aje\/kwn121","volume":"168","author":"Yousef","year":"2008","unstructured":"Yousef F, Cardwell C, Cantwell MM et al (2008) The incidence of esophageal cancer and high-grade dysplasia in Barrett\u2019s esophagus: a systematic review and meta-analysis. Am J Epidemiol 168:237\u2013249","journal-title":"Am J Epidemiol"},{"key":"1662_CR29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00428-010-0925-5","volume":"456","author":"Zemler","year":"2010","unstructured":"Zemler B, May A, Ell C, Stolte M (2010) Early Barrett\u2019s carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch 456:609\u2013614","journal-title":"Virchows Arch"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-012-1662-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1662-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:06:34Z","timestamp":1559041594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-012-1662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,26]]},"references-count":29,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1662"],"URL":"https:\/\/doi.org\/10.1007\/s00292-012-1662-0","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,26]]}}}